IMMUNOGENICITY OF INACTIVATED PURIFIED TISSUE-CULTURE VACCINE AGAINST HEPATITIS-A (HEPAVAC) ASSESSED IN LABORATORY RODENTS

被引:1
|
作者
ELBERT, LB
LISITZINA, EA
KUSOV, YY
BALAYAN, MS
机构
[1] Institute of Poliomyelitis and Virus Encephalitides, Russian Academy of Medical Sciences
关键词
TISSUE CULTURE VACCINE AGAINST HEPATITIS-A; LABORATORY RODENTS; VACCINATION SCHEDULES; ADJUVANT;
D O I
10.1016/0264-410X(92)90045-L
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immune response of laboratory rodents (guinea-pigs, CBA and Balb/c mice, Wistar and August rats) to inactivated hepatitis A vaccine was quantitatively assessed. Under comparable conditions of experiment, the mice showed the highest antibody titres and were capable of reacting to the lower doses of immunogen; meanwhile their individual variations in immune response were more pronounced; white rats were the least susceptible to the vaccine, demonstrating the minimal antibody formation; guinea-pigs produced antibody at intermediate levels but the antibody titres were the most homogeneous. The enhancing effect of aluminium hydroxide was observed in guinea-pigs examined at the late postimmunization stage. Differences in immunogenicity of three vaccine lots were essentially similar when these lots were tested as undiluted preparations in guinea-pigs and mice for mean antibody titres and in mice for 50% immune response using serial dilutions of vaccine. All three tests could be routinely employed for vaccine immunogenicity control.
引用
收藏
页码:828 / 832
页数:5
相关论文
共 50 条
  • [31] IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VACCINE IN ALASKA NATIVE CHILDREN AND NATIVE AND NONNATIVE ADULTS
    MCMAHON, BJ
    WILLIAMS, J
    BULKOW, L
    SNOWBALL, M
    WAINWRIGHT, R
    KENNEDY, M
    KRAUSE, D
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03): : 676 - 679
  • [32] INACTIVATED HEPATITIS-A VACCINE - REACTOGENICITY, IMMUNOGENICITY, AND LONG-TERM ANTIBODY PERSISTENCE
    VANDAMME, P
    THOELEN, S
    CRAMM, M
    DEGROOTE, K
    SAFARY, A
    MEHEUS, A
    JOURNAL OF MEDICAL VIROLOGY, 1994, 44 (04) : 446 - 451
  • [33] LABORATORY TESTS AND REFERENCE REAGENTS EMPLOYED IN STUDIES OF INACTIVATED HEPATITIS-A VACCINE
    BINN, LN
    MACARTHY, PO
    MARCHWICKI, RH
    SJOGREN, MH
    HOKE, CH
    BURGE, JR
    DHONDT, E
    VACCINE, 1992, 10 : S102 - S105
  • [34] A NEW INACTIVATED TISSUE-CULTURE RABIES VACCINE FOR USE IN MAN EVALUATION OF PCEC-VACCINE BY LABORATORY TESTS
    BARTH, R
    GRUSCHKAU, H
    BIJOK, U
    HILFENHAUS, J
    HINZ, J
    MILCKE, L
    MOSER, H
    JAEGER, O
    RONNEBERGER, H
    WEINMANN, E
    JOURNAL OF BIOLOGICAL STANDARDIZATION, 1984, 12 (01): : 29 - &
  • [35] ETHYLENIMINE-INACTIVATED RABIES VACCINE OF TISSUE-CULTURE ORIGIN
    LARGHI, OP
    SAVY, VL
    NEBEL, AE
    RODRIGUEZ, A
    JOURNAL OF CLINICAL MICROBIOLOGY, 1976, 3 (01) : 26 - 33
  • [36] EFFECT OF VIRUS-STRAIN AND ANTIGEN DOSE ON IMMUNOGENICITY AND REACTOGENICITY OF AN INACTIVATED HEPATITIS-A VACCINE
    GOUBAU, P
    VANGERVEN, V
    SAFARY, A
    DELEM, A
    KNOPS, J
    DHONDT, E
    ANDRE, FE
    DESMYTER, J
    VACCINE, 1992, 10 : S114 - S118
  • [37] GOOD IMMUNOGENICITY OF GBM STRAIN INACTIVATED HEPATITIS-A VACCINE IN HEALTHY MALE-ADULTS
    GARIN, D
    VIDOR, E
    WALLON, M
    FANGET, B
    BRASSEUR, P
    DELOLME, H
    CARON, F
    MOJON, M
    GRAVEY, A
    HUMBERT, G
    FLEHMIG, B
    PEYRON, F
    VACCINE, 1995, 13 (02) : 220 - 224
  • [38] IMMUNOGENICITY OF CONCENTRATED AND PURIFIED RABIES VACCINE OF TISSUE CULTURE ORIGIN
    WIKTOR, TJ
    SOKOL, F
    KUWERT, E
    KOPROWSKI, H
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1969, 131 (03): : 799 - &
  • [39] Evaluation of the reactogenicity and immunogenicity of Russian tissue culture concentrated inactivated hepatitis A vaccine Hep-A-in-Vac
    Gorbunov, MA
    Pavlova, LI
    Karpovich, LG
    Kalashnikova, TV
    Bektimirov, TA
    Levina, VD
    Maidanyuk, AG
    Yermolayeva, TN
    Shervarli, VI
    Belashev, VP
    Novikov, VY
    VOPROSY VIRUSOLOGII, 1995, 40 (05) : 219 - 221
  • [40] IMMUNOGENICITY, SAFETY, AND CONSISTENCY OF AN INACTIVATED HEPATITIS-A VACCINE - A RANDOMIZED CONTROLLED MULTICENTER STUDY WITH 3 DIFFERENT VACCINE LOTS
    KALLINOWSKI, B
    THEILMANN, L
    GMELIN, K
    KOMMERELL, B
    HOFMANN, F
    SCHEIERMANN, N
    WOHLAND, B
    STICKL, H
    MAIWALD, H
    MORIABADI, FK
    BOCK, HL
    CLEMENS, R
    INNERE MEDIZIN, 1992, 19 (02) : 41 - 44